Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model

被引:16
作者
Theodorakis, Nicholas G. [1 ]
Wang, Yining N. [1 ]
Wu, Jian-Ming [1 ]
Maluccio, Mary A. [1 ]
Sitzmann, James V. [1 ]
Skill, Nicholas J. [1 ]
机构
[1] Indiana Univ, Sch Med, Dept Surg, Indianapolis, IN 46202 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2009年 / 297卷 / 04期
关键词
mice; SMOOTH-MUSCLE-CELLS; CIRRHOTIC RATS; GASTROESOPHAGEAL VARICES; HYPERDYNAMIC CIRCULATION; NO PRODUCTION; BLOOD-FLOW; MICE; DYSFUNCTION; INHIBITION; EXPRESSION;
D O I
10.1152/ajpgi.00229.2009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Theodorakis NG, Wang YN, Wu J, Maluccio MA, Sitzmann JV, Skill NJ. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model. Am J Physiol Gastrointest Liver Physiol 297: G792-G799, 2009. First published July 23, 2009; doi: 10.1152/ajpgi.00229.2009.-Portal hypertension (PHT) is a complication of liver cirrhosis and directly increases mortality and morbidity by increasing the propensity of venous hemorrhage. There are two main underlying causations for PHT, increased hepatic resistance and systemic hyperdynamic circulation. Both are related to localized aberrations in endothelial nitric oxide synthase ( eNOS) function and NO biosynthesis. This study investigates the importance of eNOS and systemic hyperdynamic-associated hyperemia to better understand the pathophysiology of PHT. Wild-type and eNOS(-/-) mice were given the hepatotoxin CCl4 for 4-12 wk. Hepatic fibrosis was determined histologically following collagen staining. Portal venous pressure, hepatic resistance, and hyperemia were determined by measuring splenic pulp pressure (SPP), hepatic portal-venous perfusion pressure (HPVPP), abdominal aortic flow (Qao), and portal venous flow (Qpv). Hepatic fibrosis developed equally in wild-type and eNOS(-/-) CCl4-exposed mice. SPP, Qao, and Qpv increased rapidly in wild-type CCl4-exposed mice, but HPVPP did not. In eNOS(-/-) CCl4 mice, Qao was not increased, SPP was partially increased, and HPVPP and Qpv were increased nonsignificantly. We concluded that the systemic hyperemia component of hyperdynamic circulation is eNOS dependent and precedes increased changes in hepatic resistance. Alternative mechanisms, possibly involving cyclooxygenase, may contribute. eNOS maintains normal hepatic resistance following CCl4-induced fibrosis. Consequently, increased portal pressure following chronic CCl4 exposure is linked to hyperdynamic circulation in wild-type mice and increased hepatic resistance in eNOS(-/-) mice.
引用
收藏
页码:G792 / G799
页数:8
相关论文
共 44 条
[1]   Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state [J].
Abraldes, JG ;
Iwakiri, Y ;
Loureiro-Silva, M ;
Haq, O ;
Sessa, WC ;
Groszmann, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 290 (05) :G980-G987
[2]   Hepatic and mesenteric nitric oxide synthase expression in a rat model of CCl4-induced cirrhosis [J].
Bhimani, EK ;
Serracino-Inglott, F ;
Sarela, AI ;
Batten, JJ ;
Mathie, RT .
JOURNAL OF SURGICAL RESEARCH, 2003, 113 (01) :172-178
[3]   In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation [J].
Bucci, M ;
Gratton, JP ;
Rudic, RD ;
Acevedo, L ;
Roviezzo, F ;
Cirino, G ;
Sessa, WC .
NATURE MEDICINE, 2000, 6 (12) :1362-1367
[4]  
CAHILL PA, 1995, HEPATOLOGY, V22, P598, DOI 10.1002/hep.1840220233
[5]   Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats [J].
Cahill, PA ;
Redmond, EM ;
Hodges, R ;
Zhang, SM ;
Sitzmann, JV .
JOURNAL OF HEPATOLOGY, 1996, 25 (03) :370-378
[6]   Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease [J].
Feng, Hong-Qiang ;
Weymouth, Nate D. ;
Rockey, Don C. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 297 (01) :G27-G33
[7]   NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver [J].
Fiorucci, S ;
Antonelli, E ;
Brancaleone, V ;
Sanpaolol, L ;
Orlandi, S ;
Distrutti, E ;
Acuto, G ;
Clerici, C ;
Baldoni, M ;
Del Soldato, P ;
Morelli, A .
JOURNAL OF HEPATOLOGY, 2003, 39 (06) :932-939
[8]   THE EFFECT OF NITRIC-OXIDE SYNTHASE INHIBITION ON PORTAL PRESSURE AND AZYGOS BLOOD-FLOW IN PATIENTS WITH CIRRHOSIS [J].
FORREST, EH ;
JONES, AL ;
DILLON, JE ;
WALKER, J ;
HAYES, PC .
JOURNAL OF HEPATOLOGY, 1995, 23 (03) :254-258
[9]   Prevention and management of Gastroesophageal varices and variceal Hemorrhage in cirrhosis [J].
Garcia-Tsao, Guadalupe ;
Sanyal, Arun J. ;
Grace, Norman D. ;
Carey, William .
HEPATOLOGY, 2007, 46 (03) :922-938
[10]   Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice [J].
Gratton, JP ;
Lin, MI ;
Yu, J ;
Weiss, ED ;
Jiang, ZJ ;
Fairchild, TA ;
Iwakiri, Y ;
Groszmann, R ;
Claffey, KP ;
Cheng, YC ;
Sessa, WC .
CANCER CELL, 2003, 4 (01) :31-39